Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Melanoma, Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT04244552
What this trial is testing

A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies

Who this might be right for
Breast CancerColorectal CancerOvarian Cancer+13 more
Atreca, Inc. 87
Not applicableStudy completedNCT07649252
What this trial is testing

Patient Characteristics and Treatment Patterns in Real-world Melanoma Patients Treated With Dabrafenib and Trametinib or Encorafenib and Binimetinib in Japan

Who this might be right for
Melanoma
Novartis Pharmaceuticals 82
Early research (Phase 1)Ended earlyNCT05130255
What this trial is testing

GD2-SADA:177Lu-DOTA Complex in Patients With Solid Tumors Known to Express GD2

Who this might be right for
SCLCMalignant MelanomaSarcoma+1 more
Y-mAbs Therapeutics 23
Early research (Phase 1)Study completedNCT04452214
What this trial is testing

The Safety and Tolerance of CAN04 and Pembrolizumab in Combination With and Without Carboplatin and Pemetrexed in Subjects With Solid Tumors

Who this might be right for
Carcinoma, Non-Small-Cell LungUrothelial CarcinomaMalignant Melanoma+1 more
Cantargia AB 19
Testing effectiveness (Phase 2)UnknownNCT05013099
What this trial is testing

Study of Zirconium Zr 89 Crefmirlimab Berdoxam PET/CT in Subjects With Advanced or Metastatic Malignancies

Who this might be right for
MelanomaMerkel Cell Carcinoma, UnspecifiedRenal Cell Carcinoma+1 more
ImaginAb, Inc. 70
Testing effectiveness (Phase 2)Looking for participantsNCT07280832
What this trial is testing

Phase I/II Clinical Study of JMT108 Injection for the Treatment of Advanced Malignant Melanoma and Urinary Tract Tumors

Who this might be right for
Unresectable Locally Advanced or Metastatic MelanomaUnresectable Locally Advanced or Metastatic Urinary Tract Tumors
Shanghai JMT-Bio Inc. 500
Early research (Phase 1)Not Yet RecruitingNCT07183852
What this trial is testing

Locoregional or Systemic Administration of Autologous Tumor Infiltrating Lymphocytes in Patients With Metastatic Melanoma

Who this might be right for
Metastatic Uveal MelanomaMetastatic Cutaneous Melanoma
Vastra Gotaland Region 18
Testing effectiveness (Phase 2)Study completedNCT00450255
What this trial is testing

VEGF Trap in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

Who this might be right for
Ciliary Body and Choroid Melanoma, Medium/Large SizeExtraocular Extension MelanomaIris Melanoma+5 more
National Cancer Institute (NCI) 41
Testing effectiveness (Phase 2)Study completedNCT00072163
What this trial is testing

Temozolomide and Thalidomide in Treating Patients With Brain Metastases Secondary to Melanoma

Who this might be right for
Recurrent MelanomaStage IV MelanomaTumors Metastatic to Brain
National Cancer Institute (NCI) 50
Very early researchWithdrawnNCT04223648
What this trial is testing

Programmed Cell Death 1 + Selected Cell Therapy With Durvalumab (MEDI4736) and Tremelimumab in Metastatic Melanoma

Who this might be right for
Malignant Melanoma
Yale University
Large-scale testing (Phase 3)UnknownNCT00005052
What this trial is testing

Vaccine Therapy in Treating Patients With Primary Stage II Melanoma

Who this might be right for
Melanoma (Skin)
European Organisation for Research and Treatment of Cancer - EORTC
Not applicableWithdrawnNCT02507947
What this trial is testing

SPECTAmel: Screening Patients With Melanoma Tumors for Efficient Clinical Trial Access

Who this might be right for
Melanoma
European Organisation for Research and Treatment of Cancer - EORTC
Testing effectiveness (Phase 2)Study completedNCT00788775
What this trial is testing

Nilotinib in TKI Resistant or Intolerant Patients With Metastatic Mucosal, Acral, or Chronically Sun Damaged Melanoma

Who this might be right for
Mucosal Lentiginous MelanomaAcral MelanomaMelanoma
Dana-Farber Cancer Institute 20
Testing effectiveness (Phase 2)Study completedNCT00189332
What this trial is testing

Use of 852A in Metastatic Cutaneous Melanoma.

Who this might be right for
MelanomaUnresectable Metatstatic Cutaneous Melanoma
Pfizer 28
Large-scale testing (Phase 3)Active Not RecruitingNCT05987332
What this trial is testing

IDE196 (Darovasertib) in Combination With Crizotinib as First-line Therapy in Metastatic Uveal Melanoma

Who this might be right for
Metastatic Uveal Melanoma
IDEAYA Biosciences 420
Not applicableEnded earlyNCT03727087
What this trial is testing

Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Melanoma

Who this might be right for
Melanoma
Exact Sciences Corporation 348
Not applicableStudy completedNCT04490564
What this trial is testing

Validation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood and Primary Tumor in HNSCC/NSCLC/Melanoma

Who this might be right for
Head and Neck Squamous Cell CarcinomaNon Small Cell Lung CancerMelanoma
Pharmassist Ltd 135
Early research (Phase 1)Study completedNCT00112216
What this trial is testing

Immunotherapy of Melanoma Patients

Who this might be right for
Melanoma
Centre Hospitalier Universitaire Vaudois 9
Testing effectiveness (Phase 2)Study completedNCT03693612
What this trial is testing

GSK3359609 Plus Tremelimumab for the Treatment of Advanced Solid Tumors

Who this might be right for
Neoplasms
GlaxoSmithKline 26
Not applicableWithdrawnNCT04941365
What this trial is testing

Quantifying Systemic Immunosuppression to Personalize Cancer Therapy

Who this might be right for
Metastatic MelanomaMetastatic Breast CancerAdvanced Renal Cell Carcinoma+3 more
Institut du Cancer de Montpellier - Val d'Aurelle
Next Page